FindTrial
Sign In

Ayurvedic management of rheumatoid arthritis.

Management of amavata (Rheumatoid Arthritis) by comparing shiva guggulu with shatyadi kvatha and yogaraja guggulu with rasna panchaka kvatha – A randomized comparative clinical study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/06/033945
Enrollment
100
Registered
2021-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M05-M14- Inflammatory polyarthropathies

Interventions

Intervention1: Group A: 1. Shiva guggalu, 2. Shatyadi kvatha. Group B: 1. Yogaraja Guggalu, 2. Rasna panchaka kvatha: Group A: 1.Shiva guggalu: 3 tablets (Each tablet 300mg) thrice in a day after meal

Sponsors

J S AYURVEDA MAHAVIDYALAYA AND P D PATEL AYURVEDA HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of amavata: Presence of sandhishula (pain in joints), Sandhistabdhata (stiffness in joints), Sandhishitha (swelling in joints), Jvara (fever) Mandagni (lack of appetite). Diagnosis of Rheumatoid arthritis: Diagnosis of RA will be on basis of 2010 American College of Rheumatology (ACR) classifications criteria.

Exclusion criteria

Exclusion criteria: 1. Patients who have complications of rheumatoid arthritis e.g. Severe deformity of joints ones, pleura-pericardial disease. 2. Association of a joint disease of other origin. 3. Patients having uncontrolled diabetes mellitus and hypertension, active or chronic liver disorders; cardiac problem, history of cancer or lymphoproliferative disease (free of cancer for at least 1 year after carcinoma in situ can be included for study); with active tuberculosis; renal disorders, white blood cell counts less than 3000/ml and platelet count less than 100,000/ml. 4. Patients taking cortico-steroids or other immunosuppressive and biological agents from prolonged period with the history of withdrawn related severe reoccurrence. 5. Patients who have taken (are taking) any type of medicines for rheumatoid arthritis and not ready for the following washout period. 6. Pregnant/lactating women.

Design outcomes

Primary

MeasureTime frame
CHANGES IN FOLLOWING SIGN AND SYMPTOMS OF AMAVATA (RHEUMATOID ARTHRITIS): Sandhishula, sandhishotha, sandhistabdhata, restriction of movements, angamarda, aruchi, trishna, alasya, gaurava, apaka, jvara, shunta anganam.Timepoint: 0 weeks, 8 weeks—

Secondary

MeasureTime frame
CHANGES IN DAS 28 AND HAQ-DI SCORETimepoint: 0 WEEKS, 8 WEEKS—

Countries

India

Contacts

Public ContactVigna Vyas

J S Ayurveda Mahavidyalay

manishayu97@yahoo.com9979589865

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026